The Joint Clinical Assessment (JCA) framework took effect on 12th January 2025, and its impact is top of mind among pharma innovators today. The policy was the buzz of the International Society for ...
At ISPOR EU in Glasgow, a cross-stakeholder panel – ‘Optimal Strategies for Predicting and Consolidating PICOs: One Best Method or a Blended Approach?’ – tackled one of the most pressing topics for ...
A good sum of two good parts. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform a relevant index, or most peers, over a market cycle on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results